Abstract:Introduction Serotonin syndrome is a potentially life-threatening condition that is precipitated by the use of serotonergic medications, Selective Serotonin Reuptake Inhibitors (SSRIs) and Monoamine Oxidase Inhibitors (MAOIs). It usually occurs when high doses of serotonergic drugs are prescribed. It is a medical emergency that requires prompt recognition, cessation of offending drugs and supportive therapy. Objectives We present a case of serotonin syndrome that occurred in a patient who was prescribed a low dose of sertraline, and aim to highlight the importance of early detection of this severe condition. Methods Details of the case were described. Information was gathered based on medical records. Results Patient M was a 29-year-old Malay male with a history of major depressive disorder, who was previously trialed on fluvoxamine 100mg every night but subsequently switched to and maintained on sertraline 75mg every night in 2020. He then defaulted follow up appointments. In 2023, he presented to the emergency services for a suicide attempt and was diagnosed with major depressive disorder with psychotic features. He was restarted on sertraline 50mg every night and risperidone 0.5mg every night was newly started. Two days later, sertraline was increased to 100mg every night. Two days following this increase, he was noted to have altered mental state, fever of 39.3-degree celcius, tachycardia of 120 beats per minute, ocular clonus and generalized hyperreflexia. Sertraline and risperidone were immediately stopped. Blood tests including creatine kinase, lumbar puncture and magnetic resonance imaging (MRI) of the brain did not show any abnormalities. After stopping of the medications, the patient's symptoms resolved within 24 hours. Based on clinical symptoms and a normal creatine kinase level, neuroleptic malignant syndrome (NMS) was ruled out. Subsequently, he was restarted on risperidone 0.5mg and mirtazapine 7.5mg every night. He developed symptoms of serotonin syndrome with a low dose of sertraline. Symptoms resolved after the discontinuation of the SSRI. Conclusions In this case, differential diagnoses of serotonin syndrome were also considered, such as NMS, encephalitis, meningitis and thyroid storm. NMS was less likely due to the rapid onset of onset and resolution of symptoms. Encephalitis and meningitis were unlikely in view of normal MRI brain and lumbar puncture findings. There have been case reports of serotonin syndrome developing with lower doses of an SSRI in the pediatric population. There is, however, a lack of literature describing serotonin syndrome with low doses of SSRI in the adult population. To avoid a missed diagnosis, clinicians should monitor closely for SSRI toxicity, including serotonin syndrome, even when low doses of serotonergic drugs are used. Disclosure of Interest None Declared

Sertraline-Induced Hypoglycemia in Drug-Induced Liver Injury

Possible Sertraline-Induced Extrapyramidal Adverse Effects in an Adolescent.

Sertraline induces endoplasmic reticulum stress in hepatic cells.

Sertraline, an antidepressant, induces apoptosis in hepatic cells through the mitogen-activated protein kinase pathway

Sertraline-Induced Leukocytoclastic Vasculitis with Definite Causal Association: A Case Report

Serotonin Syndrome Following Low-Dose Sertraline: A Case Report

The effectiveness of sertraline in alleviating uremic pruritus in hemodialysis patients: a randomized clinical trial

A 68-Year-Old Man with Depression and Acute Renal Failure Due to Rhabdomyolysis Associated with Alcohol Intoxication While Taking Low-Dose Escitalopram: A Case Report

Acute Liver Injury Induced by Sitagliptin: Report of Two Cases and Review of Literature

Sertraline-Induced 5-HT Dysregulation in Mouse Cardiomyocytes and the Impact on Calcium Handling

Population Pharmacokinetic Modeling to Inform Sertraline Dosing Optimization in Patients with Depression

Population Pharmacokinetics of Sertraline in Psychiatric and Substance Use Disorders

Successful Pharmacologic Treatment of Self-Bloodletting with Factitious Chronic Anemia (Lasthénie de Ferjol Syndrome) with High-Dose Serotonergic Medication: A Case Report

Sertraline Pre-Treatment Attenuates Hemorrhagic Transformation Induced in Rats after Cerebral Ischemia Reperfusion via Down Regulation of Neuronal CD163: Involvement of M1/M2 Polarization Interchange and Inhibiting Autophagy

The efficacy and safety of sertraline in maintenance hemodialysis patients with depression: A randomized controlled study

Hypoglycemia After Ingestion of "Street Valium" Containing Glyburide, Alcohol, and Cocaine

S4554 Falling Through The Cracks: A Case Of Cholestatic Injury With Supratherapeutic Testosterone Supplementation

Delirium Secondary to Lamotrigine Toxicity

Psychogenic polydipsia associated with sertraline treatment: a case report

Rhabdomyolysis during adjunctive treatment with cariprazine in a clozapine-resistant schizophrenia patient

Liver Failure Associated with Benzbromarone: A Case Report and Review of the Literature.